Kura Oncology, Inc. (KURA)

Kura Oncology, Inc. (KURA) is a healthcare company (biotechnology) based in the United States. The share price is $7.49, up 5.64% on the day, which values the company at $688.17M. Price as of 18 Nov 2026, 11:36 UTC, from Yahoo Finance.

Key facts

Share price
$7.49+5.64% today
Market value
$688.17M
200-week average
$11.8537% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Kura Oncology, Inc. in more detail

KURA trades at -3.1× next year's expected earnings, 8.7× sales. It sits 37% below its 200-week average of $11.85.

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Kura Oncology, Inc. (KURA): questions and answers

What is Kura Oncology, Inc.'s market cap?

Kura Oncology, Inc. is valued at $688.17M at a share price of $7.49.

Is KURA above its 200-week moving average?

No. KURA is 36.8% below its 200-week average of $11.85. Long-term investors watch that line because strong companies rarely trade below it for long.

Does KURA pay a dividend?

Kura Oncology, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Kura Oncology, Inc. (KURA) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/KURA

Underlying data: Yahoo Finance; company filings with the SEC.